CS
TTPH

Candriam SCA’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Candriam SCA’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-781
Closed -$7K – 830
2019
Q2 		$7K Hold
781
– – ﹤0.01% 808
2019
Q1 		$21K Hold
781
– – ﹤0.01% 788
2018
Q4 		$18K Hold
781
– – ﹤0.01% 783
2018
Q3 		$43K Sell
781
-24,000
-97% -$1.53M ﹤0.01% 787
2018
Q2 		$1.77M Sell
24,781
-1,250
-5% -$88.3K 0.03% 512
2018
Q1 		$1.6M Buy
26,031
+781
+3% +$68.6K 0.03% 520
2017
Q4 		$3.18M Buy
25,250
+5,600
+28% +$717K 0.06% 362
2017
Q3 		$2.69M Buy
19,650
+9,600
+96% +$1.28M 0.05% 395
2017
Q2 		$1.43M Hold
10,050
– – 0.03% 521
2017
Q1 		$1.85M Sell
10,050
-8,650
-46% -$970K 0.04% 464
2016
Q4 		$1.51M Hold
18,700
– – 0.03% 425
2016
Q3 		$1.43M Hold
18,700
– – 0.03% 425
2016
Q2 		$1.61M Buy
18,700
+4,500
+32% +$412K 0.04% 351
2016
Q1 		$1.31M Buy
14,200
+3,520
+33% +$352K 0.03% 387
2015
Q4 		$2.14M Buy
10,680
+5,250
+97% +$1.05M 0.06% 285
2015
Q3 		$810K Sell
5,430
-1,720
-24% -$1.26M 0.02% 464
2015
Q2 		$6.78M Buy
7,150
+1,000
+16% +$818K 0.14% 188
2015
Q1 		$4.51M Buy
6,150
+3,400
+124% +$2.55M 0.09% 273
2014
Q4 		$2.18M Buy
+2,750
New +$1.48M 0.05% 348

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Candriam SCA's TTPH Position: Q3 2019 in Review

Candriam SCA sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 781 shares — an estimated $7K sold.

Candriam SCA first reported a position in TTPH in Q4 2014 and held it in 19 quarters. The position peaked at $6.78M in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • Candriam SCA reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Candriam SCA sold 781 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $7K.
  • Candriam SCA first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 19 quarters.
  • Candriam SCA's Tetraphase Pharmaceuticals, Inc. position peaked at $6.78M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.